Back to results
US 2024/0190990 A1Published application
Anti-cea antibodies and methods of use
AssigneeBeiGene Switzerland GmbH
InventorsLiang QU, Zhuo LI, Liu XUE, Qi LIU, Lin ZHU, Penghao WANG, Hanzi SUN, Xiaoyan TANG
Life of this patent
Estimating the term…
Abstract
The present disclosure provides for antibodies and antigen-binding fragments thereof that bind to human CEA, a pharmaceutical composition comprising said antibody, and use of the anti-CEA antibody or the composition for treating a disease, such as cancer.
Claims21
An anti-CEA antibody or antigen-binding fragment thereof, comprising an antibody or antigen-binding fragment thereof that specifically binds to human CEA at amino acids 596 to 674 of SEQ ID NO:52.
-18. (canceled)
Dependencies are inferred from the claim text.